top
Search terms
Results 1 - 1 of 1 - ordered by :
Ehjournal

Treatment with proprotein convertase subtilisin-kexin type 9 (PCSK9) inhibitors reduce low density lipoprotein cholesterol (LDL-C) by approximately 4560%, whether used alone or in combination with a ...

European Heart Journal, Ference, Brian A, Cannon, Christopher P, Landmesser, Ulf, Lüscher, Thomas F, Catapano, Alberico L, Ray, Kausik K

Date : 14/07/2018 Item size : 234877 bytes